Sanofi inked a deal to co-develop and commercialize oral anti-inflammatory drugs resulting from Recludix Pharma’s STAT6 platform technology. STAT6 (signal transducer and activator of transcription 6), ...
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. Thirty-four patients with cancer pain and no previous opioid treatment were randomized to receive morphine hydrochloride ...
Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study Various pharmacologic strategies have been ...
−Preclinical Proof of Concept for Oral Delivery Achieved, Demonstrating Robust, Dose-Dependent Silencing of Liver-Expressed Target in Rodents, with Durability Profile Similar to Subcutaneous ...
OTTAWA — The use of oral rather than intravenous (IV) steroids to respond to relapses in patients with relapsing-remitting multiple sclerosis (RRMS) is growing, a study suggested. The data, which were ...
In a recent study published in Nature, researchers reported on the productive and persistent infection of salivary glands (SGs) by enteric viruses, with oral cavity titers similar to intestinal titers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results